Dianthus Therapeutics, Inc. · NASDAQ:DNTH
Point72 Asset Management, L.P.'s stake in Dianthus Therapeutics, Inc. fell to 1.20% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Point72 Asset Management, L.P.'s stake in Dianthus Therapeutics, Inc. fell to 1.20%, 643,599 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 1.20%
- Shares
- 643,599
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Point72 Asset Management, L.P. | 1.20% | 643,599 |
| Point72 Capital Advisors, Inc. | 1.20% | 643,599 |
| Steven A. Cohen | 1.20% | 643,599 |
Source
Related
- Dianthus Therapeutics, Inc.
- Point72 Asset Management, L.P.
- Dianthus Therapeutics, Inc. shareholders
- Schedule 13G/A · Point72 Asset Management, L.P. · Feb 17, 2026
- Schedule 13G · Point72 Asset Management, L.P. · Sep 12, 2025
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2025
- Schedule 13G · Point72 Asset Management, L.P. · Apr 17, 2025
- Form 4 · Carr Edward · Sep 18, 2026
- Form 4 · Randhawa Simrat · Sep 3, 2026
- Form 4 · Read Simon · Aug 19, 2026
- Form 4 · Veness Adam M · Aug 14, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026